United States Supreme Court

Reset A A Font size: Print

MedImmune, Inc. v. Genentech, Inc., 05-608

Dismissal of a drug manufacturer's patent and contract declaratory judgment action, for lack of subject-matter jurisdiction, is reversed where petitioner was not required, insofar as Article III is concerned, to break or terminate its 1997 license agreement before seeking a declaratory judgment in federal court that the underlying patent was invalid, unenforceable, or not infringed.

Appellate Information

  • Decided 01/09/2007
  • Published 01/09/2007



  • United States Supreme Court